Trial Profile
Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Granisetron (Primary)
- Indications Radiotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 17 Jan 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 15 Dec 2010 Actual initiation date (Dec 2010) added as reported by ClinicalTrials.gov.
- 15 Dec 2010 Planned end date changed from 1 Oct 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.